Motivation for Treatment Correlating Most Strongly with an Increase in Satisfaction with Type 2 Diabetes Treatment
Introduction We previously reported several factors that cross-sectionally correlate with treatment satisfaction in Japanese patients with type 2 diabetes visiting diabetes clinics. The aim of this study is to identify factors associated with longitudinal changes in treatment satisfaction in patient...
Gespeichert in:
| Veröffentlicht in: | Diabetes therapy 2022-04, Vol.13 (4), p.709-721 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 721 |
|---|---|
| container_issue | 4 |
| container_start_page | 709 |
| container_title | Diabetes therapy |
| container_volume | 13 |
| creator | Motoda, Saori Watanabe, Nobuaki Nakata, Shinsuke Hayashi, Isao Komatsu, Ryoya Ishibashi, Chisaki Fujita, Shingo Baden, Megu Y. Kimura, Takekazu Fujita, Yukari Tokunaga, Ayumi Takahara, Mitsuyoshi Fukui, Kenji Iwahashi, Hiromi Kozawa, Junji Shimomura, Iichiro |
| description | Introduction
We previously reported several factors that cross-sectionally correlate with treatment satisfaction in Japanese patients with type 2 diabetes visiting diabetes clinics. The aim of this study is to identify factors associated with longitudinal changes in treatment satisfaction in patients with type 2 diabetes.
Methods
The study included 649 patients with type 2 diabetes treated with oral glucose-lowering agents who completed the first questionnaire in 2016. The collected data included scores from the Diabetes Treatment Satisfaction Questionnaire (DTSQ) and other parameters regarding diabetes treatment. We analyzed 1-year longitudinal changes in DTSQ scores and investigated factors associated with these changes.
Results
Univariate linear regression analyses showed that changes in body weight, adherence to diet therapy, adherence to exercise therapy, cost burden, motivation for treatment, regularity of mealtimes, and perceived hypoglycemia correlated with changes in DTSQ scores. On the basis of multiple linear regression analyses, a decrease in hypoglycemia (β ± SE = − 0.394 ± 0.134,
p
= 0.0034), cost burden (β ± SE = − 0.934 ± 0.389,
p
= 0.017), and an increase in treatment motivation (β ± SE = 1.621 ± 0.606,
p
= 0.0077) correlated with DTSQ score increases, suggesting that motivation for treatment had the strongest impact on score increases. Subgroup analyses revealed that an increase in motivation for treatment most significantly correlated with a DTSQ score increase in obese and poor glycemic control groups, regardless of age.
Conclusion
This is the first longitudinal study clarifying that an increase in motivation for treatment most strongly correlates with an increase in DTSQ score in patients with type 2 diabetes. |
| doi_str_mv | 10.1007/s13300-022-01235-x |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8908749</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A699823278</galeid><sourcerecordid>A699823278</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-1f48db07831df19292ff57d48ce4bb8979bd6a313e7af2f8ca3eb2ca7c8ab7da3</originalsourceid><addsrcrecordid>eNp9kt9uFCEUxonR2GbtC3hhSLzxZip_Zga4MWlWq03aeNH1mjAMTGlmYAW2dt_GZ-mTye7WXWuMcAHh_L7v5JAPgNcYnWKE2PuEKUWoQoRUCBPaVPfPwDHmraha0eLn-3tDj8BJSreoLCqEwPglOKINaRlm9Bikq5DdncoueGhDhItoVJ6Mz3AeYjRjqfgBXoWU4XWOwQ_jGv5w-QYqDy-8LnQy0Hl4XcBkld4abYHFemkefhL40anOZJMO1q_AC6vGZE4ezxn4dv5pMf9SXX79fDE_u6x0U-NcYVvzvkOMU9xbLIgg1jasr7k2dddxwUTXt4piapiyxHKtqOmIVkxz1bFe0Rn4sPNdrrrJ9Lq0jmqUy-gmFdcyKCefVry7kUO4k1wgzmpRDN49GsTwfWVSlpNL2oyj8iaskiQt5Qi3Ndugb_9Cb8Mq-jKeJIJyXGPE2IEa1Gik8zaUvnpjKs9aITihpIw7A6f_oMruzeR08Ma68v5EQHYCHUNK0dj9jBjJTVrkLi2ypEVu0yLvi-jNn7-zl_zORgHoDkil5AcTDyP9x_YX16DNJw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2938141077</pqid></control><display><type>article</type><title>Motivation for Treatment Correlating Most Strongly with an Increase in Satisfaction with Type 2 Diabetes Treatment</title><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Motoda, Saori ; Watanabe, Nobuaki ; Nakata, Shinsuke ; Hayashi, Isao ; Komatsu, Ryoya ; Ishibashi, Chisaki ; Fujita, Shingo ; Baden, Megu Y. ; Kimura, Takekazu ; Fujita, Yukari ; Tokunaga, Ayumi ; Takahara, Mitsuyoshi ; Fukui, Kenji ; Iwahashi, Hiromi ; Kozawa, Junji ; Shimomura, Iichiro</creator><creatorcontrib>Motoda, Saori ; Watanabe, Nobuaki ; Nakata, Shinsuke ; Hayashi, Isao ; Komatsu, Ryoya ; Ishibashi, Chisaki ; Fujita, Shingo ; Baden, Megu Y. ; Kimura, Takekazu ; Fujita, Yukari ; Tokunaga, Ayumi ; Takahara, Mitsuyoshi ; Fukui, Kenji ; Iwahashi, Hiromi ; Kozawa, Junji ; Shimomura, Iichiro</creatorcontrib><description>Introduction
We previously reported several factors that cross-sectionally correlate with treatment satisfaction in Japanese patients with type 2 diabetes visiting diabetes clinics. The aim of this study is to identify factors associated with longitudinal changes in treatment satisfaction in patients with type 2 diabetes.
Methods
The study included 649 patients with type 2 diabetes treated with oral glucose-lowering agents who completed the first questionnaire in 2016. The collected data included scores from the Diabetes Treatment Satisfaction Questionnaire (DTSQ) and other parameters regarding diabetes treatment. We analyzed 1-year longitudinal changes in DTSQ scores and investigated factors associated with these changes.
Results
Univariate linear regression analyses showed that changes in body weight, adherence to diet therapy, adherence to exercise therapy, cost burden, motivation for treatment, regularity of mealtimes, and perceived hypoglycemia correlated with changes in DTSQ scores. On the basis of multiple linear regression analyses, a decrease in hypoglycemia (β ± SE = − 0.394 ± 0.134,
p
= 0.0034), cost burden (β ± SE = − 0.934 ± 0.389,
p
= 0.017), and an increase in treatment motivation (β ± SE = 1.621 ± 0.606,
p
= 0.0077) correlated with DTSQ score increases, suggesting that motivation for treatment had the strongest impact on score increases. Subgroup analyses revealed that an increase in motivation for treatment most significantly correlated with a DTSQ score increase in obese and poor glycemic control groups, regardless of age.
Conclusion
This is the first longitudinal study clarifying that an increase in motivation for treatment most strongly correlates with an increase in DTSQ score in patients with type 2 diabetes.</description><identifier>ISSN: 1869-6953</identifier><identifier>EISSN: 1869-6961</identifier><identifier>DOI: 10.1007/s13300-022-01235-x</identifier><identifier>PMID: 35267173</identifier><language>eng</language><publisher>Cheshire: Springer Healthcare</publisher><subject>Cardiology ; Care and treatment ; Diabetes ; Endocrinology ; Evaluation ; Hypoglycemia ; Internal Medicine ; Longitudinal studies ; Medicine ; Medicine & Public Health ; Original Research ; Patient outcomes ; Patient satisfaction ; Questionnaires ; Regression analysis ; Type 2 diabetes</subject><ispartof>Diabetes therapy, 2022-04, Vol.13 (4), p.709-721</ispartof><rights>The Author(s) 2022</rights><rights>2022. The Author(s).</rights><rights>COPYRIGHT 2022 Springer</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-1f48db07831df19292ff57d48ce4bb8979bd6a313e7af2f8ca3eb2ca7c8ab7da3</citedby><cites>FETCH-LOGICAL-c541t-1f48db07831df19292ff57d48ce4bb8979bd6a313e7af2f8ca3eb2ca7c8ab7da3</cites><orcidid>0000-0001-9665-8947</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908749/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908749/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,41120,42189,51576,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35267173$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Motoda, Saori</creatorcontrib><creatorcontrib>Watanabe, Nobuaki</creatorcontrib><creatorcontrib>Nakata, Shinsuke</creatorcontrib><creatorcontrib>Hayashi, Isao</creatorcontrib><creatorcontrib>Komatsu, Ryoya</creatorcontrib><creatorcontrib>Ishibashi, Chisaki</creatorcontrib><creatorcontrib>Fujita, Shingo</creatorcontrib><creatorcontrib>Baden, Megu Y.</creatorcontrib><creatorcontrib>Kimura, Takekazu</creatorcontrib><creatorcontrib>Fujita, Yukari</creatorcontrib><creatorcontrib>Tokunaga, Ayumi</creatorcontrib><creatorcontrib>Takahara, Mitsuyoshi</creatorcontrib><creatorcontrib>Fukui, Kenji</creatorcontrib><creatorcontrib>Iwahashi, Hiromi</creatorcontrib><creatorcontrib>Kozawa, Junji</creatorcontrib><creatorcontrib>Shimomura, Iichiro</creatorcontrib><title>Motivation for Treatment Correlating Most Strongly with an Increase in Satisfaction with Type 2 Diabetes Treatment</title><title>Diabetes therapy</title><addtitle>Diabetes Ther</addtitle><addtitle>Diabetes Ther</addtitle><description>Introduction
We previously reported several factors that cross-sectionally correlate with treatment satisfaction in Japanese patients with type 2 diabetes visiting diabetes clinics. The aim of this study is to identify factors associated with longitudinal changes in treatment satisfaction in patients with type 2 diabetes.
Methods
The study included 649 patients with type 2 diabetes treated with oral glucose-lowering agents who completed the first questionnaire in 2016. The collected data included scores from the Diabetes Treatment Satisfaction Questionnaire (DTSQ) and other parameters regarding diabetes treatment. We analyzed 1-year longitudinal changes in DTSQ scores and investigated factors associated with these changes.
Results
Univariate linear regression analyses showed that changes in body weight, adherence to diet therapy, adherence to exercise therapy, cost burden, motivation for treatment, regularity of mealtimes, and perceived hypoglycemia correlated with changes in DTSQ scores. On the basis of multiple linear regression analyses, a decrease in hypoglycemia (β ± SE = − 0.394 ± 0.134,
p
= 0.0034), cost burden (β ± SE = − 0.934 ± 0.389,
p
= 0.017), and an increase in treatment motivation (β ± SE = 1.621 ± 0.606,
p
= 0.0077) correlated with DTSQ score increases, suggesting that motivation for treatment had the strongest impact on score increases. Subgroup analyses revealed that an increase in motivation for treatment most significantly correlated with a DTSQ score increase in obese and poor glycemic control groups, regardless of age.
Conclusion
This is the first longitudinal study clarifying that an increase in motivation for treatment most strongly correlates with an increase in DTSQ score in patients with type 2 diabetes.</description><subject>Cardiology</subject><subject>Care and treatment</subject><subject>Diabetes</subject><subject>Endocrinology</subject><subject>Evaluation</subject><subject>Hypoglycemia</subject><subject>Internal Medicine</subject><subject>Longitudinal studies</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Original Research</subject><subject>Patient outcomes</subject><subject>Patient satisfaction</subject><subject>Questionnaires</subject><subject>Regression analysis</subject><subject>Type 2 diabetes</subject><issn>1869-6953</issn><issn>1869-6961</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp9kt9uFCEUxonR2GbtC3hhSLzxZip_Zga4MWlWq03aeNH1mjAMTGlmYAW2dt_GZ-mTye7WXWuMcAHh_L7v5JAPgNcYnWKE2PuEKUWoQoRUCBPaVPfPwDHmraha0eLn-3tDj8BJSreoLCqEwPglOKINaRlm9Bikq5DdncoueGhDhItoVJ6Mz3AeYjRjqfgBXoWU4XWOwQ_jGv5w-QYqDy-8LnQy0Hl4XcBkld4abYHFemkefhL40anOZJMO1q_AC6vGZE4ezxn4dv5pMf9SXX79fDE_u6x0U-NcYVvzvkOMU9xbLIgg1jasr7k2dddxwUTXt4piapiyxHKtqOmIVkxz1bFe0Rn4sPNdrrrJ9Lq0jmqUy-gmFdcyKCefVry7kUO4k1wgzmpRDN49GsTwfWVSlpNL2oyj8iaskiQt5Qi3Ndugb_9Cb8Mq-jKeJIJyXGPE2IEa1Gik8zaUvnpjKs9aITihpIw7A6f_oMruzeR08Ma68v5EQHYCHUNK0dj9jBjJTVrkLi2ypEVu0yLvi-jNn7-zl_zORgHoDkil5AcTDyP9x_YX16DNJw</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Motoda, Saori</creator><creator>Watanabe, Nobuaki</creator><creator>Nakata, Shinsuke</creator><creator>Hayashi, Isao</creator><creator>Komatsu, Ryoya</creator><creator>Ishibashi, Chisaki</creator><creator>Fujita, Shingo</creator><creator>Baden, Megu Y.</creator><creator>Kimura, Takekazu</creator><creator>Fujita, Yukari</creator><creator>Tokunaga, Ayumi</creator><creator>Takahara, Mitsuyoshi</creator><creator>Fukui, Kenji</creator><creator>Iwahashi, Hiromi</creator><creator>Kozawa, Junji</creator><creator>Shimomura, Iichiro</creator><general>Springer Healthcare</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9665-8947</orcidid></search><sort><creationdate>20220401</creationdate><title>Motivation for Treatment Correlating Most Strongly with an Increase in Satisfaction with Type 2 Diabetes Treatment</title><author>Motoda, Saori ; Watanabe, Nobuaki ; Nakata, Shinsuke ; Hayashi, Isao ; Komatsu, Ryoya ; Ishibashi, Chisaki ; Fujita, Shingo ; Baden, Megu Y. ; Kimura, Takekazu ; Fujita, Yukari ; Tokunaga, Ayumi ; Takahara, Mitsuyoshi ; Fukui, Kenji ; Iwahashi, Hiromi ; Kozawa, Junji ; Shimomura, Iichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-1f48db07831df19292ff57d48ce4bb8979bd6a313e7af2f8ca3eb2ca7c8ab7da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cardiology</topic><topic>Care and treatment</topic><topic>Diabetes</topic><topic>Endocrinology</topic><topic>Evaluation</topic><topic>Hypoglycemia</topic><topic>Internal Medicine</topic><topic>Longitudinal studies</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Original Research</topic><topic>Patient outcomes</topic><topic>Patient satisfaction</topic><topic>Questionnaires</topic><topic>Regression analysis</topic><topic>Type 2 diabetes</topic><toplevel>online_resources</toplevel><creatorcontrib>Motoda, Saori</creatorcontrib><creatorcontrib>Watanabe, Nobuaki</creatorcontrib><creatorcontrib>Nakata, Shinsuke</creatorcontrib><creatorcontrib>Hayashi, Isao</creatorcontrib><creatorcontrib>Komatsu, Ryoya</creatorcontrib><creatorcontrib>Ishibashi, Chisaki</creatorcontrib><creatorcontrib>Fujita, Shingo</creatorcontrib><creatorcontrib>Baden, Megu Y.</creatorcontrib><creatorcontrib>Kimura, Takekazu</creatorcontrib><creatorcontrib>Fujita, Yukari</creatorcontrib><creatorcontrib>Tokunaga, Ayumi</creatorcontrib><creatorcontrib>Takahara, Mitsuyoshi</creatorcontrib><creatorcontrib>Fukui, Kenji</creatorcontrib><creatorcontrib>Iwahashi, Hiromi</creatorcontrib><creatorcontrib>Kozawa, Junji</creatorcontrib><creatorcontrib>Shimomura, Iichiro</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Motoda, Saori</au><au>Watanabe, Nobuaki</au><au>Nakata, Shinsuke</au><au>Hayashi, Isao</au><au>Komatsu, Ryoya</au><au>Ishibashi, Chisaki</au><au>Fujita, Shingo</au><au>Baden, Megu Y.</au><au>Kimura, Takekazu</au><au>Fujita, Yukari</au><au>Tokunaga, Ayumi</au><au>Takahara, Mitsuyoshi</au><au>Fukui, Kenji</au><au>Iwahashi, Hiromi</au><au>Kozawa, Junji</au><au>Shimomura, Iichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Motivation for Treatment Correlating Most Strongly with an Increase in Satisfaction with Type 2 Diabetes Treatment</atitle><jtitle>Diabetes therapy</jtitle><stitle>Diabetes Ther</stitle><addtitle>Diabetes Ther</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>13</volume><issue>4</issue><spage>709</spage><epage>721</epage><pages>709-721</pages><issn>1869-6953</issn><eissn>1869-6961</eissn><abstract>Introduction
We previously reported several factors that cross-sectionally correlate with treatment satisfaction in Japanese patients with type 2 diabetes visiting diabetes clinics. The aim of this study is to identify factors associated with longitudinal changes in treatment satisfaction in patients with type 2 diabetes.
Methods
The study included 649 patients with type 2 diabetes treated with oral glucose-lowering agents who completed the first questionnaire in 2016. The collected data included scores from the Diabetes Treatment Satisfaction Questionnaire (DTSQ) and other parameters regarding diabetes treatment. We analyzed 1-year longitudinal changes in DTSQ scores and investigated factors associated with these changes.
Results
Univariate linear regression analyses showed that changes in body weight, adherence to diet therapy, adherence to exercise therapy, cost burden, motivation for treatment, regularity of mealtimes, and perceived hypoglycemia correlated with changes in DTSQ scores. On the basis of multiple linear regression analyses, a decrease in hypoglycemia (β ± SE = − 0.394 ± 0.134,
p
= 0.0034), cost burden (β ± SE = − 0.934 ± 0.389,
p
= 0.017), and an increase in treatment motivation (β ± SE = 1.621 ± 0.606,
p
= 0.0077) correlated with DTSQ score increases, suggesting that motivation for treatment had the strongest impact on score increases. Subgroup analyses revealed that an increase in motivation for treatment most significantly correlated with a DTSQ score increase in obese and poor glycemic control groups, regardless of age.
Conclusion
This is the first longitudinal study clarifying that an increase in motivation for treatment most strongly correlates with an increase in DTSQ score in patients with type 2 diabetes.</abstract><cop>Cheshire</cop><pub>Springer Healthcare</pub><pmid>35267173</pmid><doi>10.1007/s13300-022-01235-x</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-9665-8947</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1869-6953 |
| ispartof | Diabetes therapy, 2022-04, Vol.13 (4), p.709-721 |
| issn | 1869-6953 1869-6961 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8908749 |
| source | Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Cardiology Care and treatment Diabetes Endocrinology Evaluation Hypoglycemia Internal Medicine Longitudinal studies Medicine Medicine & Public Health Original Research Patient outcomes Patient satisfaction Questionnaires Regression analysis Type 2 diabetes |
| title | Motivation for Treatment Correlating Most Strongly with an Increase in Satisfaction with Type 2 Diabetes Treatment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T10%3A53%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Motivation%20for%20Treatment%20Correlating%20Most%20Strongly%20with%20an%20Increase%20in%20Satisfaction%20with%20Type%C2%A02%20Diabetes%20Treatment&rft.jtitle=Diabetes%20therapy&rft.au=Motoda,%20Saori&rft.date=2022-04-01&rft.volume=13&rft.issue=4&rft.spage=709&rft.epage=721&rft.pages=709-721&rft.issn=1869-6953&rft.eissn=1869-6961&rft_id=info:doi/10.1007/s13300-022-01235-x&rft_dat=%3Cgale_pubme%3EA699823278%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2938141077&rft_id=info:pmid/35267173&rft_galeid=A699823278&rfr_iscdi=true |